Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project. (Q47843221)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

follicular lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andrew D Zelenetz

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

object named as

Ann S LaCasce

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Ann Vanderplas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Allison L Crosby

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Auayporn P Nademanee

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Mark S Kaminski

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Gregory A Abel

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Michael Millenson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Myron S Czuczman

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Maria A Rodriguez

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Joyce Niland

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jonathan W Friedberg

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

0 references

publication date

6 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3662-3671

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23921646%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

21 January 2018

High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Pretransplantation Treatment With Rituximab on Outcomes of Autologous Stem-Cell Transplantation for Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

7 January 2021

based on heuristic

inferred from DOI database lookup

Follicular lymphoma: to treat or not to treat is no longer the question

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28243

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47843221&oldid=1782313970"